Ali I. Al‐Gareeb
Impact in
- Biological Psychiatry top 1%
- Neurology top 0.5%
- Long-Term Effects of COVID-19
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Neurology 64
- Long-Term Effects of COVID-19 34
- Parkinson's Disease Mechanisms and Treatments 26
- Co-authors
- Hayder M. Al‐kuraishyGaber El‐Saber BatihaΑθανάσιος ΑλεξίουHebatallah M. SaadMarios PapadakisNatália MartinsAli K. AlbuhadilyThabat J. Al‐Maiahy
- Journals
- Inflammopharmacology (24 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (12 papers)Journal of Cellular and Molecular Medicine (11 papers)Ageing Research Reviews (9 papers)Journal of Advanced Pharmaceutical Technology amp Research (8 papers)
- Partner nations
- IraqEgyptSaudi Arabia
In The Last Decade
Ali I. Al‐Gareeb
336 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Biological Psychiatry 297
- Neurology 1.4k
- Neurology 630
- Infectious Diseases 1.4k
- Physiology 1.2k
Countries citing papers authored by Ali I. Al‐Gareeb
This map shows the geographic impact of Ali I. Al‐Gareeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali I. Al‐Gareeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali I. Al‐Gareeb more than expected).
Fields of papers citing papers by Ali I. Al‐Gareeb
This network shows the impact of papers produced by Ali I. Al‐Gareeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali I. Al‐Gareeb. The network helps show where Ali I. Al‐Gareeb may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ali I. Al‐Gareeb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 18 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 10 | |
| 11 | 2023 | 15 | |
| 12 | 2023 | 27 | |
| 13 | 2023 | 5 | |
| 14 | 2023 | 20 | |
| 15 | 2023 | 47 | |
| 16 | 2023 | 5 | |
| 17 | 2023 | 7 | |
| 18 | 2022 | 11 | |
| 19 | 2019 | 5 | |
| 20 | Gingko Biloba protects cardiomyocytes against acute doxorubicin induced cardiotoxicity by suppressing oxidative stress. | 2019 | 9 |
About Ali I. Al‐Gareeb
Ali I. Al‐Gareeb is a scholar working on Drug Discovery, Neurology, Biological Psychiatry, Infectious Diseases and Neurology, having authored 352 papers that have together received 6.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (60 papers), Long-Term Effects of COVID-19 (34 papers), Alzheimer's disease research and treatments (31 papers), Parkinson's Disease Mechanisms and Treatments (26 papers), Drug-Induced Hepatotoxicity and Protection (19 papers), SARS-CoV-2 and COVID-19 Research (16 papers), Lipoproteins and Cardiovascular Health (15 papers) and Nuclear Receptors and Signaling (15 papers). The work is most often cited by research in Biological Psychiatry (297 citations), Neurology (1.4k citations), Neurology (630 citations), Infectious Diseases (1.4k citations) and Physiology (1.2k citations). Ali I. Al‐Gareeb has collaborated with scholars based in Iraq, Egypt and Saudi Arabia. Frequent co-authors include Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Αθανάσιος Αλεξίου, Hebatallah M. Saad, Marios Papadakis, Natália Martins, Ali K. Albuhadily, Thabat J. Al‐Maiahy, Engy Elekhnawy and Majid S. Jabir. Their work appears in journals such as Inflammopharmacology, Naunyn-Schmiedeberg s Archives of Pharmacology, Journal of Cellular and Molecular Medicine, Ageing Research Reviews and Journal of Advanced Pharmaceutical Technology amp Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.